Csenge Advisory Group’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Sell
742
-4
-0.5% -$1.88K 0.01% 572
2026
Q1
$296K Buy
746
+15
+2% +$6.78K 0.01% 559
2025
Q4
$343K Buy
731
+4
+0.6% +$1.78K 0.02% 530
2025
Q3
$359K Sell
727
-203
-22% -$115K 0.02% 500
2025
Q2
$431K Sell
930
-12
-1% -$5.59K 0.02% 460
2025
Q1
$389K Sell
942
-33
-3% -$16K 0.02% 457
2024
Q4
$473K Sell
975
-40
-4% -$20.9K 0.03% 439
2024
Q3
$548K Sell
1,015
-1,227
-55% -$658K 0.03% 401
2024
Q2
$1.33M Buy
2,242
+297
+15% +$168K 0.08% 194
2024
Q1
$1.11M Buy
1,945
+100
+5% +$55K 0.06% 241
2023
Q4
$950K Buy
1,845
+1,191
+182% +$609K 0.06% 244
2023
Q3
$300K Buy
654
+5
+0.8% +$2.24K 0.02% 487
2023
Q2
$283K Sell
649
-9
-1% -$3.63K 0.02% 517
2023
Q1
$254K Buy
658
+11
+2% +$3.93K 0.02% 501
2022
Q4
$207K Buy
+647
New +$203K 0.02% 554
2018
Q4
Sell
-47
Closed -$4K 1286
2018
Q3
$4K Buy
+47
New +$4.48K ﹤0.01% 659

Other funds holding SNPS

Csenge Advisory Group's SNPS Position: Q2 2026 in Review

Csenge Advisory Group reduced its Synopsys (SNPS) stake by 0.54% in Q2 2026, selling an estimated $1.88K and leaving 742 shares worth $331K. The position accounts for 0.01% of the portfolio, ranked #572.

Csenge Advisory Group first reported a position in SNPS in Q3 2018 and has held it in 16 quarters since. The position peaked at $1.33M in Q2 2024. 1,448 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Csenge Advisory Group held 742 shares of Synopsys worth $331K as of Q2 2026.
  • Csenge Advisory Group sold 4 Synopsys shares in Q2 2026, an estimated $1.88K.
  • Synopsys made up 0.01% of Csenge Advisory Group's portfolio in Q2 2026, its #572 holding.
  • Csenge Advisory Group first reported a position in Synopsys in Q3 2018 and has held it in 16 quarters since.
  • Csenge Advisory Group's Synopsys position peaked at $1.33M in Q2 2024.
  • 1,448 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.